115 related articles for article (PubMed ID: 26252430)
1. Protective effect of neutralizing anti-IL-18α monoclonal antibody on a mouse model of acute graft-versus-host disease.
Li X; Zhang C; Chen W; Pan B; Kong F; Zheng K; Tang R; Zeng L
Oncol Rep; 2015 Oct; 34(4):2031-9. PubMed ID: 26252430
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
Fujimori Y; Yoshimoto T; Matsui K; Tsutsui H; Okamoto T; Kashiwamura S; Hada T; Okamura H; Kakishita E; Hara H; Nakanishi K
J Interferon Cytokine Res; 2002 Jul; 22(7):751-4. PubMed ID: 12184912
[TBL] [Abstract][Full Text] [Related]
3. Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice.
Itoi H; Fujimori Y; Tsutsui H; Matsui K; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
J Interferon Cytokine Res; 2004 May; 24(5):291-6. PubMed ID: 15153312
[TBL] [Abstract][Full Text] [Related]
4. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
5. Involvement of interleukin-18 in acute graft-versus-host disease in mice.
Itoi H; Fujimori Y; Tsutsui H; Matsui K; Sugihara A; Terada N; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
Transplantation; 2004 Nov; 78(9):1245-50. PubMed ID: 15548959
[TBL] [Abstract][Full Text] [Related]
6. Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-γ/IL-17-producing cells.
Okamoto S; Fujiwara H; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Yoshimura A; Tanimoto M; Maeda Y
J Immunol; 2015 Feb; 194(3):1357-63. PubMed ID: 25527789
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
8. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
9. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
[TBL] [Abstract][Full Text] [Related]
10. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
11. IL-35 inhibits acute graft-versus-host disease in a mouse model.
Zhang XH; Zhou Y; Zhang JM; Zhou SY; Wang M; Feng R; Feng FE; Wang QM; Zhu XL; Zhao XS; Lv M; Kong Y; Chang YJ; Huang XJ
Int Immunopharmacol; 2015 Dec; 29(2):383-392. PubMed ID: 26507167
[TBL] [Abstract][Full Text] [Related]
12. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
13. ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.
Zhang J; Ramadan AM; Griesenauer B; Li W; Turner MJ; Liu C; Kapur R; Hanenberg H; Blazar BR; Tawara I; Paczesny S
Sci Transl Med; 2015 Oct; 7(308):308ra160. PubMed ID: 26446957
[TBL] [Abstract][Full Text] [Related]
14. Signaling through the interleukin-18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury.
Nozaki Y; Kinoshita K; Yano T; Asato K; Shiga T; Hino S; Niki K; Nagare Y; Kishimoto K; Shimazu H; Funauchi M; Matsumura I
Kidney Int; 2012 Oct; 82(8):892-902. PubMed ID: 22673883
[TBL] [Abstract][Full Text] [Related]
15. [Anti-CD25 monoclonal antibody with antithymocytic globulin for steroid-resistant severe acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation].
Ye CX; Sun J; Liu QF; Qu H; Xu D; Zhang Y; Meng FY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2224-6. PubMed ID: 19114364
[TBL] [Abstract][Full Text] [Related]
16. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
17. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease.
Saito K; Yagita H; Hashimoto H; Okumura K; Azuma M
Eur J Immunol; 1996 Dec; 26(12):3098-106. PubMed ID: 8977310
[TBL] [Abstract][Full Text] [Related]
18. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
19. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
20. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
